WESTERLEIGH GROUP LIMITED
Company number 02536722 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: WESTERLEIGH GROUP LIMITED
As a financial wellness expert, I have conducted a thorough diagnostic evaluation of Westerleigh Group Limited. Just as a physician evaluates a patient's history, current symptoms, and test results, I have analysed the corporate vitals, structural genetics, and regulatory compliance of this entity to provide a comprehensive health check.
1. Financial Health Score: Provisional B+
Explanation: Westerleigh Group Limited presents as a long-standing, compliant, and structurally stable corporate entity. However, because it operates as an "Audit Exemption Subsidiary," its standalone detailed financial vitals (such as specific cash flow, profitability, and liquidity ratios) are shielded within a larger corporate group. Based on the available vital signs—excellent longevity, perfect regulatory health, and a robust share capital foundation—the patient exhibits no outward symptoms of distress. Yet, the lack of disclosed standalone financials means a definitive clean bill of health requires examining the parent company's consolidated vitals.
2. Key Vital Signs
- Pulse (Corporate Longevity & Status): Strong and steady. Incorporated in 1990, this company has a 34-year operating history. Its "Active" status and continuous operation through multiple economic cycles indicate a highly resilient constitution.
- Blood Pressure (Regulatory Compliance): Optimal. Both the annual accounts and the confirmation statement are noted as "NO" for being overdue. This indicates a healthy administrative function with no regulatory blockages or stress.
- Genetics (Ownership & Control): Consolidated immune system. The company is wholly enveloped by its parent entities, Westerleigh Group Holdings Ltd and Westerleigh Crematoria Ltd, which hold over 75% of shares, voting rights, and director appointment powers. The subsidiary relies on the broader group's financial immune system, evidenced by its audit exemption status.
- Body Mass (Capital Base): Solid. With a share capital of nearly £1.5 million, the business has a substantial capital foundation, indicating it is not a hollow shell but a meaningfully capitalised vehicle.
- Missing Lab Results (Detailed Financials): Obscured. Because the company files as an audit-exempt subsidiary, traditional vital signs like Current Assets, Current Liabilities, Net Current Assets, and P&L Reserves are not individually visible in the public record. This is a structural artifact, not necessarily a symptom of illness, but it limits standalone diagnostic depth.
3. Diagnosis
Based on the observable indicators, Westerleigh Group Limited is in stable condition with no visible symptoms of distress. The company operates in the funeral and related activities sector (SIC 96030), which is traditionally defensive and resilient to economic cycles—people unfortunately still require these essential services regardless of macroeconomic health.
The primary diagnosis to note is that Westerleigh Group Limited functions as the central nervous system (or head office, per SIC 70100) for the broader corporate body. Its financial health is intrinsically tied to its parent entities. The absence of overdue filings and the lack of any insolvency flags (administration, liquidation, receivership) confirm that the patient is not in acute crisis. The transition from a PLC in the 1990s to a Private Limited Company, and the eventual rebrand from "Westerleigh Crematoria Limited" to "Westerleigh Group Limited" in 2008, shows a healthy evolutionary adaptation, expanding its scope beyond just crematoria to a broader group structure.
4. Recommendations
- Request a Full Blood Panel (Review Consolidated Accounts): To truly gauge the financial wellness of this entity, one must look at the group's consolidated financial statements. Relying solely on the subsidiary's micro-filings is like trying to assess a patient's health by only looking at their arm—the vital organs (cash flow, debt levels, profitability) are housed in the parent company's accounts.
- Monitor the Parent's Heartbeat: Given that Westerleigh Group Holdings Ltd and Westerleigh Crematoria Ltd provide the financial life-support and guarantees, any symptoms of distress at the parent level will immediately flow down to this subsidiary. Regular credit and health checks on the parent entities are essential.
- Maintain Preventative Care: The company has an excellent record of filing compliance. Maintaining this discipline is crucial to avoiding unnecessary regulatory penalties, which act as toxins to corporate health.
- Evaluate Director Vitality: With recent officer changes (a secretary appointment and a director resignation in late 2024/2025), ensure that the new governance structure maintains the same strategic oversight and compliance standards the company has historically enjoyed.